Hansoh Pharmaceutical Group Company Limited
3692
Hisse Senetlerindeki Sıralama
#904
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Hisse Fiyatı
$4.38
Piyasa Değeri
$26.56B
Değişim (1 gün)
-0.38%
Değişim (1 yıl)
-5.15%
Ülke
CN
Ticaret Hansoh Pharmaceutical Group Company Limited (3692)
Kategori
Healthcare
Hansoh Pharmaceutical Group Company Limited (3692) için gelir
Jun 2026 itibarıyla gelir TTM: $2.30B
Hansoh Pharmaceutical Group Company Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $2.30B'dir. 2023 yılında şirketin geliri $1.43B önceki yıla göre artış 2022 yılındaki $1.36B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Hansoh Pharmaceutical Group Company Limited için 2016 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2026 (TTM) | $2.30B | 37.16% |
| 2024 | $1.68B | 17.68% |
| 2023 | $1.43B | 4.94% |
| 2022 | $1.36B | -12.98% |
| 2021 | $1.56B | 17.51% |
| 2020 | $1.33B | 6.68% |
| 2019 | $1.25B | 11.07% |
| 2018 | $1.12B | 18.09% |
| 2017 | $950.71M | 21.49% |
| 2016 | $782.52M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 186.97% |
IN
|
